Fund Holdings — Yiheng Capital Management, L.P.

Total Portfolio Value:
$302.34M
Total Bought:
$16.22M
Total Sold:
$16.81M
Net Transaction:
-$583.1K
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Noah Holdings LimitedADS(NOAH)6,719,7226,717,351-2,371$80.23M$77.85M25.75%-$2.38M
Bilibili IncADS1,918,5641,418,564-500,000$41.15M$39.85M13.18%-$1.31M
New Oriental Education & Technology Group Inc.ADR(EDU)598,080521,901-76,179$32.27M$27.70M9.16%-$4.57M
JD.com, Inc.CL A(JD)787,413787,4130$25.70M$27.54M9.11%+$1.84M
H World Group LimitedADS(HTHT)488,964457,032-31,932$16.59M$17.87M5.91%+$1.29M
Inventiva S.A.ADS(IVA)2,644,9262,644,9260$8.44M$15.31M5.07%+$6.88M
ATRenew Inc.ADS(RERE)3,163,1173,163,1170$10.47M$14.55M4.81%+$4.08M
ACM Research, Inc.CL A(ACMR)280,201280,2010$7.26M$10.96M3.63%+$3.71M
Viridian Therapeutics, Inc.(VRDN)500,261500,2610$6.99M$10.80M3.57%+$3.80M
Akero Therapeutics Inc299,791191,076-108,715$16.00M$9.07M3.00%-$6.92M
Kymera Therapeutics, Inc.(KYMR)122,605122,6050$5.35M$6.94M2.30%+$1.59M
Denali Therapeutics Inc.(DNLI)469,981469,9810$6.58M$6.82M2.26%+$249.1K
Ultragenyx Pharmaceutical Inc.(RARE)0225,758+225,758$0$6.79M2.25%+$6.79M
DBV Technologies S.A.ADS(DBVT)656,309656,3090$6.01M$6.56M2.17%+$551.4K
Silvaco Group, Inc.(SVCO)1,096,2821,096,2820$5.17M$5.93M1.96%+$756.4K
Pony AI Inc.ADS(PONY)0200,300+200,300$0$4.50M1.49%+$4.50M
Cellebrite DI Ltd.(CLBT)0231,031+231,031$0$4.28M1.42%+$4.28M
TAL Education GroupADS(TAL)309,240309,2400$3.16M$3.46M1.15%+$303.1K
Agora, Inc.ADS(API)533,547533,5470$2.03M$2.04M0.67%+$5.3K
Beam Therapeutics Inc.(BEAM)69,05869,0580$1.17M$1.68M0.55%+$501.4K
Yatsen Holding LimitedADS(YSG)96,32896,3280$928.6K$872.7K0.29%-$55.9K
Generation Bio Co0105,524+105,524$0$645.8K0.21%+$645.8K
Tuniu CorporationADS(TOUR)314,437314,4370$264.8K$299.4K0.10%+$34.7K
Generation Bio Co1,055,2690-1,055,269$337.8K$0—-$337.8K
Page 1 of 1
Yiheng Capital Management, L.P. — 13F Holdings — Q3 2025 | TickerTrail